Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs CCEP✓SelectedUSD · CCEPGSK vs CCEP performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs CCEP

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+44.4%
CCEP return
+147.2%
Excess return
-102.8%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioCCEPExcessAlpha
1D+0.5%+1.4%-0.9%+0.1%
7D+1.1%+2.1%-1.0%+0.5%
30D+6.3%+10.6%-4.2%+3.0%
3M+1.8%+10.3%-8.5%-1.4%
6M+1.7%+31.1%-29.4%-6.8%
YTD+6.5%+32.1%-25.6%-2.4%
1Y+9.5%+32.8%-23.3%+0.1%
3Y+65.3%+111.3%-46.0%+33.7%
All+44.4%+147.2%-102.8%+7.1%

Cumulative growth

Daily Returns

Daily percentage return beside CCEP.

Daily Out/Under-Performance

Portfolio return minus CCEP return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CCEP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded CCEP wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling